Charachterization of umbilical cord mesenchymal stromal cells during long-term expansion in vitro
- Authors: Aizenshtadt A.A.1, Skazina M.A.2, Kotelevskaya E.A.2, Yelsukova L.V.2, Zolina T.L.2, Ponomartsev N.V.3, Galaktionov N.K.3, Galembo I.A.2, Ivolgin D.A.1, Maslennikova I.I.1, Enukashvily N.I.1
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- Stem Cell Bank Pokrovsky
- Institute of Cytology RAS
- Issue: Vol 10, No 1 (2018)
- Pages: 11-19
- Section: Reviews
- URL: https://journals.rcsi.science/vszgmu/article/view/8806
- DOI: https://doi.org/10.17816/mechnikov201810111-19
- ID: 8806
Cite item
Full Text
Abstract
One of the clinicians’ major concerns is the biological safety of MSC. The critical question for clinical application of human MSC is their ability to undergo spontaneous malignant transformation in a recipient organism. The goal of our research was to study umbilical cord hMSC proliferative and differentiation capacities, karyotype stability, telomerase activity and telomere length, oncomarkers expression and tumorigenicity during long-term (6 months) cultivation ex vivo. Here we report on the establishing the primary culture of human umbilical cord MSC, MSC_0714, that was capable to proliferate ex vivo for up to 59 passages (6 months). During this period, the cells preserved their normal karyotype, morphology and MSC immunophenotype. Telomeres started to shorten only after the passage 20, while hTERT was inactive in these cells for the whole period of expansion. At the beginning of cultivation the number of SA-β-gal positive cells did not exceeded 3-5%, after the 22th passage their number started to increase and reached 49% at the passage 57. Thus, it was shown that MSC during long-term culture retain their characteristics and undergo cell senescence.
Full Text
##article.viewOnOriginalSite##About the authors
A. A. Aizenshtadt
North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
M. A. Skazina
Stem Cell Bank Pokrovsky
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
E. A. Kotelevskaya
Stem Cell Bank Pokrovsky
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
L. V. Yelsukova
Stem Cell Bank Pokrovsky
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
T. L. Zolina
Stem Cell Bank Pokrovsky
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
N. V. Ponomartsev
Institute of Cytology RAS
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
N. K. Galaktionov
Institute of Cytology RAS
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
I. A. Galembo
Stem Cell Bank Pokrovsky
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
D. A. Ivolgin
North-Western State Medical University named after I.I. Mechnikov
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
I. I. Maslennikova
North-Western State Medical University named after I.I. Mechnikov
Email: nie@newmail.ru
Russian Federation, Saint Petersburg, Russia
N. I. Enukashvily
North-Western State Medical University named after I.I. Mechnikov
Email: nie@newmail.ru
Russian Federation, Saint Petersburg
References
- Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. doi: 10.1080/14653240600855905.
- Furno DL, Mannino G, Giuffrida R. Functional Role of Mesenchymal Stem Cells in the Treatment of Chronic Neurodegenerative Diseases. J Cell Physiol. 2018;233(5):3982-3999. doi: 10.1002/jcp.26192.
- Epstein SE, Luger D, Lipinski MJ. Paracrine-Mediated Systemic Anti-Inflammatory Activity of Intravenously Administered Mesenchymal Stem Cells: A Transformative Strategy for Cardiac Stem Cell Therapeutics. Cir Res. 2017;121(9):1044-1046. doi: 10.1161/CIRCRESAHA.117.311925.
- Mohseny AB, Szuhai K, Romeo S, et al. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol. 2009;219(3):294-305. doi: 10.1002/path.2603.
- Torsvik A, Røsland GV, Svendsen A, et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track-letter. Cancer Res. 2010;70(15):6393-6396. doi: 10.1158/0008-5472.CAN-10-1305.
- Tao H, Lin Y, Zhang G, et al. Experimental observation of human bone marrow mesenchymal stem cell transplantation into rabbit intervertebral discs. Biomed Rep. 2016;5(3):357-360. doi: 10.3892/br.2016.731.
- Katsiani E, Garas A, Skentou C, et al. Chorionic villi derived mesenchymal like stem cells and expression of embryonic stem cells markers during long-term culturing. Cell and Tissue Banking. 2016;17(3):517-529. doi: 10.1007/s10561-016-9559-4.
- Jeong SG, Cho GW. Accumulation of apoptosis-insensitive human bone marrow-mesenchymal stromal cells after long-term expansion. Cell Biochemistry and Function. 2016;34(5):310-316. doi: 10.1002/cbf.3191.
- Danisovic L, Oravcova L, Krajciova L, et al. Effect of long-term culture on the biological and morphological characteristics of human adipose tissue-derived stem cells. J Physiol Pharmacol. 2017;68(1):149-158.
- Nikitina V, Astrelina T, Nugis V, et al. Clonal chromosomal and genomic instability during human multipotent mesenchymal stromal cells long-term culture. PLoS One. 2018;13(2):e0192445. doi: 10.1371/journal.pone.0192445.
- Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6):1384-1392. doi: 10.1634/stemcells.2006-0709.
- Айзенштадт А.А., Енукашвили Н.И., Золина Т.Л., и др. Сравнение пролиферативной активности и фенотипа МСК, полученных из костного мозга, жировой ткани и пупочного канатика // Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. – 2015. – Т. 7. – № 2. – С. 14–22. [Aisenstadt AA, Enukashvili NI, Zolina TL. Comparison of proliferation and immunophenotype of MSK, obtainedfrom bone marrow, adipose tissue and umbilical cord. Herald of North-Western State Medical University named after I.I. Mechnikov. 2015;7(2):14-22. (In Russ.)]
- Ma YH, Zeng X, Qiu XC, et al. Perineurium-like sheath derived from long-term surviving mesenchymal stem cells confers nerve protection to the injured spinal cord. Biomaterials. 2018;160:37-55. doi: 10.1016/j.biomaterials.2018.01.015.
- Wang Y, Zhang Z, Chi Y, et al. Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death Dis. 2013;4(12):e950. doi: 10.1038/cddis.2013.480.
- Hao H, Chen G, Liu J, et al. Culturing on Wharton’s jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways. PLoS One. 2013;8(3):e58314. doi: 10.1371/journal.pone.0058314.
- Kundrotas G, Gasperskaja E, Slapsyte G, et al. Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow. Oncotarget. 2016;7(10):10788-802. doi: 10.18632/oncotarget.7456.